Home›Companies›Biotech & Pharma›Radionetics Oncology

Radionetics Oncology, Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 15, 2023·Suggest an edit

About Radionetics Oncology

Radionetics Oncology is a private company based in Menlo Park, California, incorporated in 2021 in Delaware. It has reported $54,211,759 raised in one offering on Form D since August 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 1, 2023Aug 15, 2023$54,211,759of $68.7M target6$9.0MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Radionetics Oncology's Form D filed Aug 15, 2023.

BE
Brett Ewald
Interim Chief Operating Officer
AS
UG
Umesh Gangadharmath
Executive officer
DE
Dan Estes
Executive officer and director
IM
Istvan Molnar
Executive officer
YZ
Yunfei Zhu
Executive officer
AK
Ana Kusnetzow
Executive officer
SS

Sources

  1. SECRadionetics Oncology, Inc. filing history